ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "education, patient"

  • Abstract Number: 1151 • ACR Convergence 2021

    Experiences and Finding Meaning Among Latin Americans Living with Lupus: Learning from Social Media Narratives by Patients and Their Social Network

    Tirsa Colmenares-Roa1, Alfonso Gastelum-Strozzi2, Erica Crosley3, Yurilis Fuentes-Silva4, Cristina Reategui-Sokolova5, Claudia Elera-Fitzcarrald6, Soledad Ibañez7, Ernesto Cairoli8, Bernardo A. Pons-Estel9, Ingris Peláez-Ballestas1 and Cristina Drenkard10, 1Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico, Mexico, 2Instituto de Ciencias Aplicadas y Tecnología, Universidad Nacional Autónoma de México, Mexico, Mexico, 3John Hopkins University, Baltimore, MD, 4Division of Rheumatology, Complejo Hospitalario Universitario Ruiz y Páez, Universidad de Oriente, Ciudad Bolívar, Centro Nacional de Enfermedades Reumáticas, Ciudad Bolívar, Venezuela, 5Hospital Guillermo Almenara Irigoyen, Lima, Peru, 6Universidad Cientifica del Sur/Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 7Sanatorio Güemes, Buenos Aires, Argentina, 8Autoimmune Diseases Unit, Centro Asistencial del Sindicato Médico del Uruguay (CASMU) and Hospital Evangélico, Montevideo, Uruguay, 9Grupo Oroo - Centro Regional de Enfermedades Autoinmunes y Reumticas (GO-CREAR), Rosario, Argentina, 10Emory University, Atlanta, GA

    Background/Purpose: SLE disproportionately affects Latin Americans, and outcomes are worse amongst them compared to non-minority populations. Understanding patients' views of living with SLE is critical…
  • Abstract Number: 1152 • ACR Convergence 2021

    A Follow-Up Evaluation of a Longstanding Telephone Peer Counseling Service for People with Systemic Lupus Erythematosus and Their Loved Ones

    Priscilla Toral, Roberta Horton and Jillian Rose, Hospital for Special Surgery, New York, NY

    Background/Purpose: With technology rapidly evolving, studies still reinforce the value of telephone peer support for people living with chronic illness. A follow-up evaluation was conducted…
  • Abstract Number: 1153 • ACR Convergence 2021

    The Influence of Companions on a Patient’s Decision to Transition to a Biosimilar: A Randomized Controlled Trial

    Chiara Gasteiger1, Katie Groom1, Maria Lobo2, Urte Scholz3, Keith Petrie1 and Nicola Dalbeth1, 1University of Auckland, Auckland, New Zealand, 2Auckland District Health Board, Auckland, New Zealand, 3University of Zurich, Zurich, Switzerland

    Background/Purpose: Involving patients in treatment decisions is commonplace in healthcare, but patients are frequently accompanied by a support person (companion). Companions are often actively involved…
  • Abstract Number: 1154 • ACR Convergence 2021

    What Do Patients Know About Biosimilars and How Satisfied Are They with the Educational Process? – A Systematic Comparison Between Rheumatologists and Nurse Specialists, Including Effects of Multiswitching

    Sabina Gall, Uta Kiltz, Tanja Kobylinski, Ioana Andreica, Kristina Vaupel, Xenofon Baraliakos and Jürgen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: The market share of biosimilars (bsDMARDs) is steadily growing, not only in rheumatologic care. Although data on efficacy, efficiency and safety have been generated…
  • Abstract Number: 1157 • ACR Convergence 2021

    Patient Perspective on the Non Medical Switch of Originator to Its Biosimilar in Inflammatory Arthritis Using a Social Media Survey

    David Vega Morales1, Alejandro Garza-Alpirez2 and Carlos Andrés Díaz-Garza2, 1Hospital Universitario, Garcia, Mexico, 2Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro, Mexico

    Background/Purpose: The use of biosimilars instead of its originator is a controversial subject with many implications. It is considered that a non medical switch should…
  • Abstract Number: 0107 • ACR Convergence 2021

    Acceptability of the COVID-19 Vaccine in Patients with Rheumatic Diseases and Healthcare Professionals in 19 Arab Countries

    Lina El Kibbi1, Mona Metawee1, Ihsane Hmamouchi2, Nizar Abdulateef3, Hussein Halabi4, Mervat Eissa5, Manal El Rakawi6, Basel Masri7, Fatemah Abutiban8, Wafa Hamdi9, Asal Adnan3, Antonella Abi Najm10, Renaud Felten11, Laurent Arnaud11 and Nelly Ziade12, 1Specialized Medical Center, Riyadh, Saudi Arabia, 2Rheumatology Unit, Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, 3Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq, 4King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, 5Cairo University, Cairo, Egypt, Cairo, Egypt, 6Rheumatology Department, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria, 7Jordan Hospital, Amman, Jordan, 8Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait City, Kuwait, 9Rheumatology Department, Kassab Institute of Orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia, 10Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon, 11Department of Rheumatology, French National Reference Center for Autoimmune Diseases (CRMR RESO), Strasbourg, France, 12Rheumatology Department, Saint-Joseph Medical University and Hotel-Dieu de France Hospital, Beirut, Lebanon

    Background/Purpose: The first COVID-19 vaccines were authorized in December 2020. However, their acceptability remains debated and has never been evaluated in patients with chronic rheumatic…
  • Abstract Number: 1159 • ACR Convergence 2021

    Improving Healthcare Transition Implementation: Recommendations from Young Patients with Rheumatic Conditions

    Courtney Wells1, Peter Chira2, Dana Guglielmo3, Stacy Ardoin4, Katelyn Melcher5, Meghan Trimble6 and Kristine Carandang7, 1University of Wisconsin-River Falls, White Bear Lake, MN, 2Pediatric Rheumatology, University of California San Diego, Rady Children’s Hospital, San Diego, CA, 3Student, Atlanta, GA, 4Nationwide Children's Hospital, Columbus, OH, 5Patient Partner, Ankeny, IA, 6Patient Partner, Minneapolis, MN, 7Independent, San Diego, CA

    Background/Purpose: Implementation of structured healthcare transition processes remains elusive for most US rheumatology clinics (Johnson et al., 2021). Although research studies have proposed models and…
  • Abstract Number: 0147 • ACR Convergence 2021

    A Qualitative Analysis of Methotrexate Self-Injection Education Videos on YouTube: An Update

    Amy Semaka, Hillary Wilson and Steven Katz, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Patients are turning to the Internet for guidance and information at an increasing rate, requiring clinicians to be aware of the constantly changing resources…
  • Abstract Number: 1451 • ACR Convergence 2021

    Improving Health Outcomes and Social Connectedness Through Virtual Exercise Programs in Community Members with Musculoskeletal Conditions

    Titilayo Ologhobo1, Bertilia Trieu2, Claudia Zurlini1, Bonnie McGrath1, Linda Roberts1, Vilma Briones1, Pamela Sanchez-Villagomez2, Robyn Wiesel1, Sandra Goldsmith1 and Laura Robbins1, 1Hospital for Special Surgery, New York, NY, 2Hospital of Special Surgery, New York

    Background/Purpose: According to the 2020 American Health Ranking System, 26% of adults are physically inactive with a higher prevalence found in adults ages ≥65 years.…
  • Abstract Number: 0225 • ACR Convergence 2021

    Prevalence of Sexual Dysfunction and Depression in German Patients with Psoriasis and Psoriatic Arthritis – Results of the PIPPA Study

    Sebastian Saur1, Alexandra Schloegl2, Caroline Höppner3, Anastasia Gubar2, Katharina Meier4, Matthias Hahn2 and Jorg Henes2, 1Universtiy Hostpiatl Tübingen, Tuebingen, Germany, 2University Hospital Tuebingen, Tuebingen, Germany, 3Charite Berlin, Berlin, Germany, 4Department of Dermatology, Venereology and Allergology – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Berlin, Germany

    Background/Purpose: As known chronic inflammatory diseases have an impact on sexuality. To date, there are only a few studies from North and Latin America which…
  • Abstract Number: 1592 • ACR Convergence 2021

    ACT for Lupus: Pilot Study of a Novel Acceptance and Commitment Therapy (ACT) Online Program to Support Patients with Lupus During the COVID-19 Pandemic

    Tessa Englund1, Saira Sheikh2, Becki Cleveland1, Emily McCormick1, Crystal Schiller3 and Teresa Dickson1, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 2University of North Carolina Thurston Arthritis Research Center, and Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 3University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic disease associated with significant symptom burden, including fatigue, anxiety, depression, pain, and negative impacts on health-related quality…
  • Abstract Number: 0233 • ACR Convergence 2021

    Feasibility and Acceptability of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change

    Katherine Carpenter1, Melissa French1, Sara Balestrieri2, Sara Johnson2, Sarah Gilman3, Cristina Drenkard4, S Sam Lim5, Maria Dall'Era6, Emily Somers7, Suzanna Zick8, Victoria Werth9, Daniel Wallace10, Melicent Miller1 and Mary Crimmings1, 1Lupus Foundation of America, Washington, DC, 2Pro-Change Behavior Systems, South Kingstown, RI, 3Wayfinder Health Strategies, Falls Church, VA, 4Emory University, Atlanta, GA, 5Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 6University of California San Francisco, Corte Madera, CA, 7University of Michigan, Ann Arbor, MI, 8Department of Family Medicine and Nutritional Sciences, Ann Arbor, MI, 9Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, 10Cedars-Sinai, Los Angeles, CA

    Background/Purpose: The Lupus Foundation of America (LFA) has completed a 5-year cooperative agreement with the CDC to develop and evaluate an online lupus self-management (SM)…
  • Abstract Number: 1711 • ACR Convergence 2021

    Increasing Preeclampsia Knowledge in SLE with a Specific Educational Tool: Preliminary Results

    Joo Young (Esther) Lee1, Arielle Mendel2, Isabelle Malhamé2, Sasha Bernatsky1 and Evelyne Vinet3, 1McGill University, Montréal, QC, Canada, 2McGill University Health Centre, Montréal, QC, Canada, 3McGill University Health Centre, Mont Royal, QC, Canada

    Background/Purpose: Pregnant women with systemic lupus erythematosus (SLE) are at high risk of preeclampsia, leading to substantial maternal and fetal morbidity. Aspirin reduces preeclampsia risk…
  • Abstract Number: 0367 • ACR Convergence 2021

    Can Belonging to an AxSpA Patient Organization Be Associated with Benefits to Its Members? Results from the European Map of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Souzi Makri2, Denis Poddubnyy3, Christine Bundy4, Laura Christen5, Sergio Sanz-Gomez6, José Correa-Fernández6, Raj Mahapatra7, Carlos Jesús Delgado-Domínguez6 and Victoria Navarro-Compán8, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 3Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 4Cardiff University, Cardiff, Wales, United Kingdom, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 7Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 8Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain

    Background/Purpose: Patient organizations (POs) provide education and support services aimed to improve the quality of life of axSpA patients. This analysis aims to identify factors…
  • Abstract Number: 1716 • ACR Convergence 2021

    Teratogenic Medication Use Associated with Favorable Odds of Contraception Counseling in a Cohort of Women with Systemic Lupus Erythematosus at a Large Tertiary Academic Medical Center

    Shruti Chandramouli1, Carolina Alvarez2, R. Gina Silverstein3 and Saira Sheikh4, 1Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Department of Obstetrics & Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4University of North Carolina Thurston Arthritis Research Center, and Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) primarily affects women of childbearing age, who have an increased risk of pregnancy complications such as preterm labor and preeclampsia,…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology